Lupin Limited — Famotidine Exporter Profile
Indian Pharmaceutical Exporter · #9 for Famotidine · $1.3M export value · DGFT Verified
Lupin Limited is the #9 Indian exporter of Famotidine with $1.3M in export value and 26 verified shipments. Lupin Limited holds a 2.3% market share in Famotidine exports across 2 countries. The company exports 38 pharmaceutical products worth $271.4M across 19 therapeutic categories.
Lupin Limited — Famotidine Export Profile: Buyers & Destinations
Where Does Lupin Limited Export Famotidine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $702.2K | 25 | 93.4% |
| SAUDI ARABIA | $50.0K | 1 | 6.6% |
Lupin Limited exports Famotidine to 2 countries. The largest destination is UNITED STATES accounting for 93.4% of Lupin Limited's Famotidine shipments. These destinations reflect Lupin Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Famotidine from Lupin Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UPS SUPPLY CHAIN SOLUTIONS | UNITED STATES | $702.2K | 25 |
| AL-RAZI PHARMACEUTICAL INDUSTRIES.. | SAUDI ARABIA | $50.0K | 1 |
Lupin Limited supplies Famotidine to 2 buyers globally. The largest buyer is UPS SUPPLY CHAIN SOLUTIONS (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Famotidine Export Value and How Much Does Lupin Limited Contribute?
India exported $40.4M worth of Famotidine through 2,750 shipments from 152 suppliers to 66 countries, serving 302 buyers globally. Lupin Limited contributes $1.3M to this total, accounting for 2.3% of India's Famotidine exports. Lupin Limited ships Famotidine to 2 countries through 2 buyers.
What Is the Average Shipment Value for Lupin Limited's Famotidine Exports?
Lupin Limited's average Famotidine shipment value is $50.0K per consignment, based on 26 shipments totaling $1.3M. The largest destination is UNITED STATES (93.4% of Lupin Limited's Famotidine exports).
How Does Lupin Limited Compare to Other Indian Famotidine Exporters?
Lupin Limited ranks #9 among 152 Indian Famotidine exporters with a 2.3% market share. The top 3 exporters are VKT PHARMA PRIVATE LIMITED ($8.7M), ANNORA PHARMA PRIVATE LIMITED ($8.1M), MYLAN LABORATORIES LIMITED ($7.5M). Lupin Limited processed 26 shipments to 2 destination countries.
What Famotidine Formulations Does Lupin Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FAMOTIDINE F.O.S. USP 40MG/5ML (US)( FAMOTIDINE FOR ORAL SUSPENSION USP 40MG/5ML) - 1 BTL x 50ML | $169.3K | 5 |
| FAMOTIDINE F.O.S. USP 40MG/5ML 50ML(US)( | $121.6K | 4 |
| PHARMA : FAMOTIDINE F.O.S.USP 40MG/5ML US FAMOTIDINE FOR ORAL SUSPENSION USP40MG/5ML - 1BTLx50ML OTHER-ANTIULCER | $100.0K | 2 |
| PHARMA : FAMOTIDINE F.O.S.USP 40MG/5ML (US) (FAMOTIDINE FOR ORAL SUSPENSION USP40MG/5ML) - 1BTLSX50ML | $80.9K | 4 |
| PHARMA : FAMOTIDINE F.O.S.USP 40MG/5ML ( | $55.6K | 2 |
| FAMOTIDINE FOS USP 40MG/5ML 50ML-SAUDI ( FAMOTIDINE FOR ORAL SUSPENSION USP)NOS | $50.0K | 1 |
| FAMOTIDINE F.O.S. USP 40MG/5ML (US)(FAMOTIDINE FOR ORAL SUSPENSION USP 40MG/5ML)-1 BTL x 50ML(OTHERS-ANTIULCER) | $41.0K | 1 |
| PHARMA : FAMOTIDINE F.O.S. USP 40MG/5ML(US) (FAMOTIDINE FOR ORAL SUSPENSION USP40MG/5ML) - 1BTLx50ML | $38.1K | 1 |
| FAMOTIDINE F O S USP 40MG 5ML US FAMOTIDINE FOR ORAL SUSPENSION USP 40MG 5ML 1 BTL x 50ML | $34.7K | 2 |
| FAMOTIDINE F.O.S. USP 40MG/5ML (US)(FAMOTIDINE FOR ORAL SUSPENSION USP 40MG/5ML) 1 BTL X 50ML( OTHERSANTIULCER) | $25.4K | 1 |
Lupin Limited exports 13 distinct Famotidine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FAMOTIDINE F.O.S. USP 40MG/5ML (US)( FAMOTIDINE FOR ORAL SUS with 5 shipments worth $169.3K.
Regulatory Requirements: Exporting Famotidine to Key Markets
What Lupin Limited must comply with to export Famotidine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Lupin Limited Compare to Nearest Famotidine Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | ALKEM LABORATORIES LIMITED | $1.6M | 40 | 1 | $40.5K |
| 5 | APOTHECON PHARMACEUTICALS PRIVATE LIMITED | $1.6M | 31 | 3 | $50.0K |
| 9 | LUPIN LIMITED ★ | $1.3M | 26 | 2 | $50.0K |
| 11 | MARKSANS PHARMA LIMITED | $1.2M | 106 | 2 | $11.4K |
| 6 | MEDREICH LIMITED | $1.1M | 23 | 1 | $50.0K |
Lupin Limited ranks #9 among 152 Indian Famotidine exporters. Average shipment value of $50.0K compared to the market average of $265.7K. The closest competitors by value are ALKEM LABORATORIES LIMITED and APOTHECON PHARMACEUTICALS PRIVATE LIMITED.
Which Indian Ports Ship Famotidine Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 264 | 9.6% |
| HYDERABAD ICD | 251 | 9.1% |
| SAHAR AIR | 239 | 8.7% |
| DELHI AIR | 188 | 6.8% |
| NHAVA SHEVA SEA (INNSA1) | 163 | 5.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 155 | 5.6% |
| HYDERABAD ICD (INSNF6) | 153 | 5.6% |
| HYDERABAD AIR | 86 | 3.1% |
Geopolitical & Trade Policy Impact on Lupin Limited's Famotidine Exports
Lupin's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, thereby escalating shipping costs for Indian exporters. (sgexports.odoo.com) Additionally, the 2025 United States–India diplomatic and trade crisis resulted in the U.S. imposing a 50% tariff on Indian exports, significantly affecting the competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org)
Conversely, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) poses compliance challenges for Indian exporters, including Lupin, necessitating adherence to stringent carbon reporting requirements. However, the EU's focus on reducing dependency on Chinese pharmaceutical imports presents an opportunity for Indian companies to capture a larger share of the European market.
Lupin Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Lupin's global operations. In February 2025, the U.S. FDA completed a Pre-Approval Inspection at Lupin's Somerset, New Jersey facility with zero observations, reflecting the company's commitment to compliance and quality. (lupin.com) However, the evolving regulatory landscape, including the EU's falsified medicines directive and the U.S. FDA's increasing scrutiny, necessitates continuous investment in quality assurance and regulatory compliance to ensure uninterrupted market access.
About Lupin Limited
Lupin Limited exports 38 products worth $271.4M. Beyond Famotidine, top products include Isoniazid, Cephalexin, Simvastatin, Rifampicin, Amlodipine. View the complete Lupin Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Famotidine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Famotidine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Lupin Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 26 individual customs records matching Lupin Limited exporting Famotidine, covering 13 formulations to 2 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 66+ countries, 302+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Famotidine Export Data from Lupin Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lupin Limited's Famotidine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lupin Limited
Full Company Profile →
38 products · $271.4M total trade · 19 categories
Famotidine Stats
Company Overview
Top Products by Lupin Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Lupin Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Famotidine. For current shipment-level data, contact TransData Nexus.